Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study

被引：0
|
作者：
Loebel, A. [1 ]
Cucchiaro, J. [1 ]
Silva, R. [1 ]
Sarma, K. [1 ]
Kroger, H. [1 ]
Calabrese, J. R. [2 ]
Sachs, G. [3 ,4 ]
机构：
[1] Sunovion Pharmaceut Inc, Ft Lee, NJ USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Massachusetts Gen Hosp, Bipolar Clin, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Res Program, Boston, MA 02114 USA
来源：
BIPOLAR DISORDERS | 2013年 / 15卷
关键词：
bipolar disorder; depression; atypical antipsychotics; randomized clinical trial;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study
    Katagiri, Hideaki
    Tohen, Mauricio
    McDonnell, David P.
    Fujikoshi, Shinji
    Case, Michael
    Kanba, Shigenobu
    Takahashi, Michihiro
    Gomez, Juan-Carlos
    BMC PSYCHIATRY, 2013, 13
  • [42] Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study
    Hideaki Katagiri
    Mauricio Tohen
    David P McDonnell
    Shinji Fujikoshi
    Michael Case
    Shigenobu Kanba
    Michihiro Takahashi
    Juan-Carlos Gomez
    BMC Psychiatry, 13
  • [43] Vortioxetine Treatment for Depression in Alzheimer's Disease: A Randomized, Double-blind, Placebo-controlled Study
    Jeong, Hye Won
    Yoon, Kyung Hee
    Lee, Chang Hyun
    Moon, Yoo Sun
    Kim, Do Hoon
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (02) : 311 - 319
  • [44] Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression
    Mitsukuni Murasaki
    Tsukasa Koyama
    Shigenobu Kanba
    Masahiro Takeuchi
    Yuriko Shimizu
    Eri Arita
    Kentaro Kuroishi
    Masahiro Takeuchi
    Shinya Kamei
    Psychopharmacology, 2018, 235 : 2859 - 2869
  • [45] Cognitive effects of creatine monohydrate adjunctive therapy in patients with bipolar depression: Results from a randomized, double-blind, placebo-controlled trial
    Toniolo, Ricardo Alexandre
    Ferreira Fernandes, Francy de Brito
    Silva, Michelle
    Dias, Rodrigo da Silva
    Lafer, Beny
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 224 : 69 - 75
  • [46] Effect of Korean Red Ginseng in individuals exposed to high stress levels: a 6-week, double-blind, randomized, placebo-controlled trial
    Baek, Ji Hyun
    Heo, Jung-Yoon
    Fava, Maurizio
    Mischoulon, David
    Choi, Kwan Woo
    Na, Eun Jin
    Cho, Hana
    Jeon, Hong Jin
    JOURNAL OF GINSENG RESEARCH, 2019, 43 (03) : 402 - 407
  • [47] Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study
    Terra, JL
    Montgomery, SA
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (02) : 55 - 62
  • [48] A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression
    Bauer, Isabelle E.
    Green, Charles
    Colpo, Gabriela D.
    Teixeira, Antonio L.
    Selvaraj, Sudhakar
    Durkin, Katherine
    Zunta-Soares, Giovana B.
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (01)
  • [49] The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
    Wu, Suet-Kei
    Yang, Kai-Jie
    Liu, Wen-Chun
    Malau, Ikbal Andrian
    Zailani, Halliru
    Chang, Cheng-Ho
    Huang, Shih-Yi
    Chang, Jane Pei-Chen
    Chiu, Wei-Che
    Su, Kuan-Pin
    NUTRIENTS, 2024, 16 (21)
  • [50] Achieving and Sustaining Remission in Bipolar I Disorder with ZiprasidoneA Post Hoc Analysis of a 24-Week, Double-Blind, Placebo-Controlled Study
    Chi-Un Pae
    Prakash S. Masand
    Francine S. Mandel
    Cedric O’Gorman
    Clinical Drug Investigation, 2012, 32 : 747 - 754
12345